Buspirone Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 5 mg, 7.5 mg, 10 mg, 15 mg, 30 mg
Reference Brands: Generics mainly and Buspar®(dis.cntd)
Category:
Antipsychotropic Drugs
Buspirone is an anxiolytic that acts as a partial agonist at serotonin 5-HT1A receptors and has some dopamine D2 receptor antagonism. Unlike benzodiazepines, it does not cause sedation, dependency, or muscle relaxation, making it a safer option for long-term use. Buspirone tablets are used for the management of generalized anxiety disorder (GAD) and the short-term relief of anxiety symptoms without the risk of significant cognitive impairment or withdrawal effects.
Buspirone Tablets is available in Tablets
and strengths such as 5 mg, 7.5 mg, 10 mg, 15 mg, 30 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Buspirone Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Buspirone Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Buspirone tablets are FDA-approved in the United States for the management of generalized anxiety disorder (GAD) or the short-term relief of anxiety symptoms. As a non-scheduled medication, it offers a safer alternative to benzodiazepines with no risk of dependence. Manufacturing requires compliance with GMP standards, validated bioequivalence data for generics, and adherence to CNS safety labeling. In the European Union, buspirone is authorized via national procedures for similar indications. EU regulations require Risk Management Plans (RMPs) and post-marketing pharmacovigilance. To explore dossier-ready Buspirone tablets for global B2B sourcing, visit Pharmatradz.com.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing